High rate of tumor shrinkage amongst pancreatic cancer patients: study
Adding cisplatin to the standard gemcitabine/nab-paclitaxel drug treatment provided a very high rate of tumor shrinkage for individuals with advanced pancreatic cancer, according to the results of a pilot clinical demo conducted by the HonorHealth Research Start and the Translational Genomics Research Start (TGen).
Related Posts:Radioimmunotherapy, Gemcitabine combination shows early…Tucatinib (ONT-380) progressing in pivotal demo against…Fox Chase trial tests promising therapy in early breast…New nanopharmaceutical may help overcome resistance to…The antibody that normalizes tumor vesselsThe po...
Source: My Irritable Bowel Syndrome Story - April 25, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
New bowel disorder treatments needed, FOOD AND DRUG ADMINISTRATION says
(HealthDay)—There’s no known cause or cure for irritable bowel syndrome (IBS), which affects more than 15 million Americans, based on the U. S. Food and Drug Management.
Related Posts:FOOD AND DRUG ADMINISTRATION approves new drugs for…Eluxadoline eases pain and diarrhea for a few with IBSNew study indicates why children are likelier to develop…Zelnorm By Novartis: Risks Outweigh BenefitsProtein from bacteria alleviates food allergic reactionsThe post New bowel disorder treatments needed, FOOD AND DRUG ADMINISTRATION says appeared first on My Irritable Bowel Syndrome Story. (Source: My Irritable Bowel Syndrome Story)
Source: My Irritable Bowel Syndrome Story - April 17, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Growth necrosis factor found to straight regulate blood pressure
Investigators in the Ted Rogers Centre for Heart Research have discovered a surprising new role for tumor necrosis factor (TNF): namely, that it is a major regulator associated with small blood vessel function, the important thing determinant of blood pressure. The study is certainly published online today in Nature Communications.
Related Posts:The antibody that normalizes tumor vesselsNew blood test could help millions of patients with…Research finds new link between zonulin and two common…Glucosuria apps among top 10 doctors recommend in order to…Associated with sepsis negated by Tie2 activation-ind...
Source: My Irritable Bowel Syndrome Story - April 6, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Brand new immunotherapy combination shows promise for patients with advanced melanoma
Treatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable responses in a number of patients with advanced melanoma, including some whose melanoma had progressed despite prior treatment with an immune gate inhibitor, and fewer than anticipated undesirable events, according to results from a stage Ib clinical trial presented here at the AACR Annual Meeting 2017, April 1-5.
Related Posts:Radioimmunotherapy, Gemcitabine combination shows early…New nanopharmaceutical may help overcome resistance to…Tucatinib (ONT-380) progressing in pivotal demo against…Analy...
Source: My Irritable Bowel Syndrome Story - April 5, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Researchers develop 3-D tissue culture versions to mmic human gut infections
Vaccines and antimicrobials did more to transform medicine plus extend the average human lifespan than any other scientific breakthrough. Yet infectious diseases remain the world’s number 1 leading cause of death of kids and young adults.
Related Posts:Brand new frontiers of fecal microbiota hair transplantCleveland Clinic’s preventive breast cancer vaccine…Special protein interaction may drive most common genetic…Connection between genes that make cells deaf to messages…Several with nonceliac wheat sensitivity have autoimmune…The post Researchers develop 3-D tissue culture versions ...
Source: My Irritable Bowel Syndrome Story - March 10, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Urine-based biomarkers for early cancer testing test
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science with UNIST has recently developed a new method that effectively identifies cancer-causing ingredients in the urine or blood.
Related Posts:Research team identifies a neuron signal controlling…The antibody that normalizes tumor vesselsNew blood test could help millions of patients with…Brand new optogenetic tool for controlling neuronal…Associated with sepsis negated by Tie2 activation-induced…The post Urine-based biomarkers for early cancer testing test appeared first on My Irritable Bowel Syndrome Story. (Source: My Irritab...
Source: My Irritable Bowel Syndrome Story - March 7, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Intestinal bacteria alter gut and human brain function
Research from McMaster University has found that bacterias in the gut impacts both digestive tract and behavioural symptoms in sufferers suffering from irritable bowel syndrome (IBS), a finding which could lead to brand new microbiota-directed treatments.
Related Posts:Immune cell’s role in intestinal movement may lead to…Moving capsule shows promising results in dealing with…Connection between genes that make cells deaf to messages…Rifimax to Treat IBSBrand new frontiers of fecal microbiota hair transplantThe post Intestinal bacteria alter gut and human brain function appeared first on My Irrita...
Source: My Irritable Bowel Syndrome Story - March 1, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
UNC Lineberger launches innovative cellular immunotherapy program
University of North Carolina Lineberger Comprehensive Cancer Center experts have achieved a major milestone using the launch of two clinical tests testing an experimental therapy by which patients’ own immune cells are usually genetically engineered to fight their cancer.
Related Posts:MUSC launches first clinical trial regarding two powerful…Drug shows surprising efficacy as therapy for chronic…CTCA at Western Regional Medical Center advances combinationFox Chase trial tests promising therapy in early breast…Why male immune cells are from Mars and female cells are…The post UNC Lineberger ...
Source: My Irritable Bowel Syndrome Story - February 28, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Genome surgery with CRISPR-Cas9 to prevent blindness
It is estimated that almost one in every ten people over 65 has its own signs of age-related macular degeneration (AMD), and its prevalence is likely to increase as a result of the aging population. AMD is a form of blindness, common in Caucasians, which in turn causes distorted vision and blind spots. Researchers at the Center for Genome Architectural, within the Institute for Basic Science (IBS) report the use of CRISPR-Cas9 in performing “gene surgery” in the coating of tissue that supports the particular retina of living mice. Released in Genome Research, this study combines basic research and mouse design ...
Source: My Irritable Bowel Syndrome Story - February 16, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Why male immune cells are from Mars and female cells are usually from Venus
Michigan State University researchers are the first to uncover reasons why a specific type of immune cellular acts very differently in females compared to males while under stress, resulting in women being more susceptible to certain diseases.
Related Posts:Immune cell’s role in intestinal movement may lead to…Group suppresses oxidative stress and neuronal death…Connection between genes that make cells deaf to messages…Drug shows surprising efficacy as therapy for chronic…Researchers create a multifunctional endoscopeThe post Why male immune cells are from Mars and female cells are usually...
Source: My Irritable Bowel Syndrome Story - February 7, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Food and antibiotics may change microorganisms within gut, causing IBS
A recent review of research suggests that changes to the microorganisms (microbiota) in the gastrointestinal (GI) tract may be a cause of irritable bowel syndrome (IBS). The review article is published in the American Diary of Physiology—Gastrointestinal and Liver Physiology.
Related Posts:Combining epigenetic therapies with immunotherapies likely…IBS and bloating: When the gut microbiota gets out of…Evaluation suggests yoga beneficial in irritable bowel…Non-celiac wheat sensitivity may be an allergy5 fast facts about norovirusThe post Food and antibiotics may change microorganisms within gut, causin...
Source: My Irritable Bowel Syndrome Story - January 27, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Tucatinib (ONT-380) progressing in pivotal demo against HER2+ breast cancer
Stage 1 clinical trial data published this week in the journal Clinical Malignancy Research show early promise from the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The particular 50 women treated had advanced despite a median 5 earlier treatment regimens. Twenty-seven percent of the heavily pretreated patients saw scientific benefit from the drug, with at least “stable disease” at 24 or more days after the start of treatment. These data led to two subsequent Phase Ib studies, resulting in tucatinib earning FDA fast-track status and the enlargement of this study on...
Source: My Irritable Bowel Syndrome Story - January 11, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
IRRITABLE BOWEL SYNDROME affects women ’ s quality of life more than mens
Double work and a higher embarrassment factor can lead to the quality of life being affected more among women than men by irritable bowel syndrome (IBS), a very common gastrointestinal disease. Even with the same level of actual pain and other symptoms, women’s recognized quality of life is worse than the mens, according to new research.
Related Posts:IBS and bloating: When the gut microbiota gets out of…New drug to help common bowel conditionIs Ibs Considered A Physical Disability?What is Irritable Bowel SyndromeAnxiety and Depression Thanks To IBSThe post IRRITABLE BOWEL SYNDROME affects women’s qualit...
Source: My Irritable Bowel Syndrome Story - January 9, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Rifaximin effective for repeat treatment of IRRITABLE BOWEL SYNDROME with diarrhea
(HealthDay)—Repeat treatment with the nonsystemic antibiotic rifaximin works well in patients with relapsing symptoms of diarrhea-predominant irritable bowel syndrome (IBS-D), according to a study published in the December issue of Gastroenterology.
Related Posts:Evaluation suggests yoga beneficial in irritable bowel…Eluxadoline eases pain and diarrhea for a few with IBSTreatment for IBS With Severe ConstipationRifimax to Treat IBSLow FODMAP diet cuts irritable bowel syndrome symptomsThe post Rifaximin effective for repeat treatment of IRRITABLE BOWEL SYNDROME with diarrhea appeared first on My Irritable Bowel Syn...
Source: My Irritable Bowel Syndrome Story - December 27, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Type of psychotherapy matters in treatment of irritable bowel syndrome
Worldwide, roughly one adult in 10 is suffering from a painful and sometimes debilitating situation called irritable bowel syndrome, or IBS.
Related Posts:Anxiety and Depression Thanks To IBSConnection between genes that make cells deaf to messages…Treatment for IBS With Severe ConstipationPsychotherapies have long-term benefit for those suffering…Headache, tension headaches and irritable bowel syndrome…The post Type of psychotherapy matters in treatment of irritable bowel syndrome appeared first on My Irritable Bowel Syndrome Story. (Source: My Irritable Bowel Syndrome Story)
Source: My Irritable Bowel Syndrome Story - December 12, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
